Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods.
about
Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocciPrevention of catheter-related bloodstream infections in patients on hemodialysis: challenges and management strategiesPhenotypic and molecular characterization of Staphylococcus aureus isolates expressing low- and high-level mupirocin resistance in Nigeria and South AfricaClinical and bacteriological efficacy of twice daily topical retapamulin ointment 1% in the management of impetigo and other uncomplicated superficial skin infections.Staphylococcus aureus: Screening for Nasal Carriers in a Community Setting with Special Reference to MRSAMupirocin resistance related to increasing mupirocin use in clinical isolates of methicillin-resistant Staphylococcus aureus in a pediatric population.Current practice in Staphylococcus aureus screening and decolonization.Methicillin and Vancomycin Resistant S. aureus in Hospitalized Patients.Association of high-level mupirocin resistance and multidrug-resistant methicillin-resistant Staphylococcus aureus at an academic center in the midwestern United StatesUse of the surgical wound infection model to determine the efficacious dosing regimen of retapamulin, a novel topical antibiotic.Efficacy of skin and nasal povidone-iodine preparation against mupirocin-resistant methicillin-resistant Staphylococcus aureus and S. aureus within the anterior nares.Interstrain interactions between bacteria isolated from vacuum-packaged refrigerated beefTwenty Percent of Patients May Remain Colonized With Methicillin-resistant Staphylococcus aureus Despite a Decolonization Protocol in Patients Undergoing Elective Total Joint Arthroplasty.MupB, a new high-level mupirocin resistance mechanism in Staphylococcus aureus.In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis.In vivo activity of a novel polymeric guanidine in experimental skin infection with methicillin-resistant Staphylococcus aureusCurrent options for the treatment of impetigo in children.Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.Screening of Staphylococcus aureus, Staphylococcus intermedius, and Staphylococcus schleiferi isolates obtained from small companion animals for antimicrobial resistance: a retrospective review of 749 isolates (2003-04).Aminoacyl-tRNA synthetases: essential and still promising targets for new anti-infective agents.Microbiological profile of a new topical antibacterial: retapamulin ointment 1%.Prevention of access-related infection in dialysis.Cost-effectiveness of preoperative nasal mupirocin treatment in preventing surgical site infection in patients undergoing total hip and knee arthroplasty: a cost-effectiveness analysis.Bacterial resistance and impetigo treatment trends: a review.Community-associated methicillin-resistant Staphylococcus aureus and athletes.Oxacillin- and mupirocin-resistant Staphylococcus aureus: in vitro activity of silver sulphadiazine and cerium nitrate in hospital strains.Ozenoxacin 1% cream in the treatment of impetigo: a multicenter, randomized, placebo- and retapamulin-controlled clinical trial.Systemic bioavailability and safety of twice-daily topical ozenoxacin 1% cream in adults and children with impetigo.Evaluation of analogs of reutericyclin as prospective candidates for treatment of staphylococcal skin infections.Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.Analysis of mupirocin resistance and fitness in Staphylococcus aureus by molecular genetic and structural modeling techniques.Prevalence of Extended Spectrum β-Lactamase and Antimicrobial Susceptibility Pattern of Clinical Isolates of Pseudomonas from Patients of Khyber Pakhtunkhwa, Pakistan.Topical retapamulin in the management of infected traumatic skin lesions.In Vitro susceptibility of methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus to a new antimicrobial, copper silicate.Antibacterial activity of REP8839, a new antibiotic for topical use.Mode of action and biochemical characterization of REP8839, a novel inhibitor of methionyl-tRNA synthetase.Transient loss of high-level mupirocin resistance in Staphylococcus aureus due to MupA polymorphism.Ozenoxacin: a review of absorption, dermal exposure and toxicity, tolerability and safety studies.Activity of mupirocin and 14 additional antibiotics against staphylococci isolated from Latin American hospitals: report from the SENTRY antimicrobial surveillance program.Surveillance for mupirocin resistance among methicillin-resistant Staphylococcus aureus clinical isolates.
P2860
Q24549464-C040CEF8-3792-403F-B64E-DA33F1B52C0FQ26752915-BC842664-2B73-4332-8DB7-FCA7E2980412Q33403622-722C1934-F3FC-4FDE-BAF2-362945EF447DQ33640273-0B413BB9-3D14-4421-B4CD-DD1086371878Q33905359-7A5A8199-7E4B-4763-AA33-012EA2F397A4Q33963464-E1231CE4-84A5-4B46-9CDB-AA57A8AC5A75Q34022819-7D766672-B529-4377-937E-E6B9369D46A8Q34142160-EE41FC99-7387-4DB8-8CD0-7ED5C167C98AQ34487570-733710F3-DAF7-4772-B887-4372593ED64DQ34572086-E5B04B2B-C2D2-4BCC-837E-C0146BA6C486Q35385754-BDE65F43-89BF-414E-990E-DBDFA1ED61B0Q35557919-F7B5ED25-F35B-419B-ADE5-8EACFBEE2CC7Q35689295-5589EA14-B1ED-4010-ACE4-68BC41E8B071Q35867526-832B9240-2978-4DC1-BB1C-158E1345F250Q35870415-2AF317A4-425A-4FDC-A6A2-32E037A275A3Q36094796-1523DCF9-E632-450C-AFF0-7CC3D6E3E64AQ36283726-448389FD-0E8C-4AAC-91B9-AA312BDA9FB8Q36320180-6BA5F60B-A88E-47C5-9402-5CC9F640C0A7Q36589495-88289A74-5A6D-475F-9C7E-96678F9EED50Q36802598-9902F068-04D5-4F81-92C2-F2020555E69CQ37432080-0BB3404F-410D-438F-8F91-2390946D49CCQ37646705-58AFBD57-7375-4414-B07A-371C2B6A6DFDQ37974091-D2ADDEE3-457E-4A03-B675-B2A67C40907FQ37980796-1669F54C-BF56-47F9-BDE7-1E7CEA645919Q38023627-6EB03E2E-DD7C-457F-B441-D4DA6EF62BA3Q38333798-BC87B852-F8CC-4A88-B459-E7B429F65921Q39108901-6FD1BE7F-C62A-4737-A5FA-2972ECFDA260Q39131194-07FB0D4E-7FA7-4E75-B11A-ECD48F6C208AQ39828418-DD7F2661-6E4A-43D9-A331-9E6140DECEFFQ39985562-3EC1BA8B-8709-472E-8F50-3C413519C71DQ40289356-B4D9FF45-E26A-4710-AD50-705CCC65BE8CQ40629064-F5DC280A-7740-463C-BC0A-13167F3EE51DQ41435804-C6E8A187-3A4C-42D9-B023-552D49771757Q41928905-18876B41-6311-4136-8B5A-855C8FAFD0E7Q42112582-F0103EE5-F90A-4D52-A2BF-1316FA6A9F11Q42565043-FD3C4ADA-2623-4CD2-845E-58B4E06D1AC2Q42747691-BA50E6F0-865C-42B1-89C9-8A268C6A2932Q44114539-713C1395-D0D5-4275-86E8-C269A1DF652EQ45033375-B7375CF2-C4FC-4D1B-8EB5-B492ED7F09B8Q46353491-B7F01F5C-9E23-4AAA-9F13-CF0DC3D26CEC
P2860
Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Emerging elevated mupirocin re ...... nd reference dilution methods.
@en
Emerging elevated mupirocin re ...... nd reference dilution methods.
@nl
type
label
Emerging elevated mupirocin re ...... nd reference dilution methods.
@en
Emerging elevated mupirocin re ...... nd reference dilution methods.
@nl
prefLabel
Emerging elevated mupirocin re ...... nd reference dilution methods.
@en
Emerging elevated mupirocin re ...... nd reference dilution methods.
@nl
P2093
P1476
Emerging elevated mupirocin re ...... nd reference dilution methods.
@en
P2093
L M Deshpande
M A Pfaller
SENTRY Antimicrobial Surveillance Program Participants Group
P304
P356
10.1016/S0732-8893(01)00328-5
P577
2002-04-01T00:00:00Z